Free Trial
OTCMKTS:IPCIF

Intellipharmaceutics International (IPCIF) Stock Price, News & Analysis

Intellipharmaceutics International logo

About Intellipharmaceutics International Stock (OTCMKTS:IPCIF)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
12,042 shs
Market Capitalization
$4.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IPCIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellipharmaceutics International and its competitors with MarketBeat's FREE daily newsletter.

IPCIF Stock News Headlines

Intellipharmaceutics International Inc. (IPCI.TO)
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

IPCIF Stock Analysis - Frequently Asked Questions

Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) issued its quarterly earnings data on Monday, July, 16th. The company reported ($0.70) EPS for the quarter, hitting analysts' consensus estimates of ($0.70). The company had revenue of $0.58 million for the quarter, compared to the consensus estimate of $0.90 million.

Intellipharmaceutics International's stock reverse split before market open on Friday, September 14th 2018.The 1-10 reverse split was announced on Thursday, September 13th 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of IPCIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/16/2018
Today
7/07/2025
Fiscal Year End
11/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:IPCIF
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$660 thousand
Price / Cash Flow
N/A
Book Value
($0.32) per share
Price / Book
N/A

Miscellaneous

Free Float
32,511,000
Market Cap
$4.96 million
Optionable
Not Optionable
Beta
1.53
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (OTCMKTS:IPCIF) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners